EarningsQ2 2024 Earnings Report

Agios Pharma (8AP) Q2 2024 Earnings Report

0 Followers

DE:8AP Q2 2024 EPS Results

Actual EPS-€1.51

Consensus EPS-€1.43

Beat/MissMissed by -€0.08

One Year Ago EPS-€1.35

Actual Revenue€7.69M

Expected Revenue€8.34M

Beat/MissMissed by -€650.50K

YoY Revenue Growth+28.35%

QuarterQ2 2024

Date08/01/2024

TimeBefore Open

Conference CallThursday, August 1, 2024

DE:8AP Upcoming Earnings

Agios Pharma's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:8AP Q2 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-1.11 / -	-1.588	―
Jul 30, 2026	2026 (Q2)	-1.48 / -1.51	-1.722	12.44% (+0.21)
Apr 29, 2026	2026 (Q1)	-1.61 / -1.51	-1.383	-9.03% (-0.12)
Feb 12, 2026	2025 (Q4)	-1.74 / -1.66	-1.285	-29.17% (-0.37)
Oct 30, 2025	2025 (Q3)	-1.69 / -1.59	14.473	-110.97% (-16.06)
Jul 31, 2025	2025 (Q2)	-1.61 / -1.72	-1.508	-14.20% (-0.21)
May 01, 2025	2025 (Q1)	-1.58 / -1.38	-1.294	-6.90% (-0.09)
Feb 13, 2025	2024 (Q4)	-1.51 / -1.28	-1.526	15.79% (+0.24)
Oct 31, 2024	2024 (Q3)	13.58 / 14.47	-1.463	1089.02% (+15.94)
Aug 01, 2024	2024 (Q2)	-1.43 / -1.51	-1.347	-11.92% (-0.16)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed